Dow Down 0.18% Nasdaq Up 0.39%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.72 0.02(0.35%) Sep 2, 4:00PM EDT
|After Hours : 5.74 Up 0.02 (0.35%) Sep 2, 7:03PM EDT
Prev Close:5.70
Open:5.76
Bid:5.67 x 200
Ask:14.33 x 1000
1y Target Est:9.75
Beta:1.61
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.63 - 5.85
52wk Range:4.60 - 7.82
Volume:2,342,078
Avg Vol (3m):3,528,880
Market Cap:700.89M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OREX

Comparison

Symbol% ChgMkt Cap
OREXUp 0.35%700.89M
ABT63.50B
GSK115.99B
RHHBY248.42B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):203.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.26
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback